Carnegie Arch Capital is a New York-based venture capital firm associated with Arch. It invests in the United States and has participated in later-stage venture financings, including Series C rounds, with sector exposure that includes Cannabis. The firm is relevant for founders seeking later-stage U.S. venture capital.